A recent study showed that a MYCN-targeting PI- polyamide, MYCN-A3, binds to and alkylates DNA within the MYCN transcript, resulting in a decrease in MYCN copy number, downregulation of MYCN expression and suppression of NB growth in vitro and in xenografts (167). The gene discussed is MYCN; the disease is neuroblastoma.